Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle

Medical Hypotheses

Volumn 77, Issue 4, 2011, Pages 658-661

  Glueck, Charles J ^a   Abuchaibe, Cesar ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ERGOCALCIFEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MYALGIA; MYOSITIS; RETREATMENT; RISK REDUCTION; SKELETAL MUSCLE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; VITAMIN D DEFICIENCY;

EID: 80052627012     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.007     Document Type: Article

References (33)

1. [1]. Ghatak A, Faheem O, Thompson PD. The genetics of statin-induced myopathy. Atherosclerosis, 2009.
2. Nichols G.A., Koro C.E. Does statin therapy initiation increase the risk for myopathy? An observational study of 32, 225 diabetic and nondiabetic patients. Clin Ther 2007, 29:1761-1770.
3. Glueck C.J., Aregawi D., Agloria M., et al. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies. Clin Ther 2006, 28:933-942.
4. Siddiqi S.A., Thompson P.D. How do you treat patients with myalgia who take statins?. Curr Atheroscler Rep 2009, 11:9-14.
5. Lee P., Greenfield J.R., Campbell L.V. Vitamin D insufficiency-a novel mechanism of statin-induced myalgia?. Clin Endocrinol (Oxf) 2009, 71:154-155.
6. McClure D.L., Valuck R.J., Glanz M., Murphy J.R., Hokanson J.E. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol 2007, 60:812-818.
7. Ahmed W., Khan N., Glueck C.J., et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009, 153:11-16.
8. Thompson P.D., Clarkson P., Karas R.H. Statin-associated myopathy. Jama 2003, 289:1681-1690.
9. Bell D.S. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 2010, 103:690-692.
10. Duell PB CW. Vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins (Abstract). Circulation 2008;118:Suppl S470.
11. Harper C.R., Jacobson T.A. Evidence-based management of statin myopathy. Curr Atheroscler Rep 2010, 12:322-330.
12. Gupta A., Thompson P.D. The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 2011, 215:23-29.
13. Holick M.F., Chen T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008, 87:1080S-1086S.
14. Mark S., Gray-Donald K., Delvin E.E., et al. Low vitamin D status in a representative sample of youth from Quebec, Canada. Clin Chem 2008, 54:1283-1289.
15. Goswami R., Mishra S.K., Kochupillai N. Prevalence and potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 2008, 127:229-238.
16. Alsafwah S., Laguardia S.P., Nelson M.D., et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008, 335:292-297.
17. Adams J.S., Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010, 95:471-478.
18. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006, 65:593-597.
19. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics, 2009.
20. Jorde R., Sneve M., Hutchinson M., Emaus N., Figenschau Y., Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010, 171:903-908.
21. Erkal M.Z., Wilde J., Bilgin Y., et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 2006, 17:1133-1140.
22. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br J Nutr 2003, 89:552-572.
23. Pfeifer M., Begerow B., Minne H.W. Vitamin D and muscle function. Osteoporos Int 2002, 13:187-194.
24. Shinchuk L.M., Holick M.F. Vitamin D and rehabilitation: improving functional outcomes. Nutr Clin Pract 2007, 22:297-304.
25. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004, 80:752-758.
26. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006, 92:4-8.
27. Bunout D., Barrera G., Leiva L., et al. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Exp Gerontol 2006, 41:746-752.
28. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
29. Lang J.E., Wang P., Glueck C.J. Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism. Clin Chim Acta 1996, 254:65-92.
30. Molden E., Andersson K.S. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. Pharmacotherapy 2007, 27:603-607.
31. Hurst F.P., Neff R.T., Jindal R.M., et al. Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation. Nephrol Dial Transp 2009, 24:3861-3866.
32. Tsugawa N., Suhara Y., Kamao M., Okano T. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem 2005, 77:3001-3007.
33. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.